Diffusion-weighted magnetic resonance imaging for the prediction of pathologic response to neoadjuvant chemoradiotherapy in esophageal cancer

Radiotherapy and Oncology

Volumn 115, Issue 2, 2015, Pages 163-170

  Van Rossum, Peter S N ^a   Van Lier, Astrid L H M W ^a   Van Vulpen, Marco ^a   Reerink, Onne ^a   Lagendijk, Jan J W ^a   Lin, Steven H ^b   Van Hillegersberg, Richard ^a   Ruurda, Jelle P ^a   Meijer, Gert J ^a   Lips, Irene M ^a  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^b UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

Chemoradiotherapy; Diffusion weighted MRI; Esophageal cancer; Functional imaging; Neoadjuvant therapy

Indexed keywords

CARBOPLATIN; PACLITAXEL;

ADULT; AGED; AREA UNDER THE CURVE; ARTICLE; CANCER ADJUVANT THERAPY; CANCER GRADING; CANCER STAGING; CHEMORADIOTHERAPY; CLINICAL ARTICLE; DIAGNOSTIC ACCURACY; DIFFUSION COEFFICIENT; DIFFUSION WEIGHTED IMAGING; ESOPHAGEAL ADENOCARCINOMA; ESOPHAGEAL SQUAMOUS CELL CARCINOMA; EXPLORATORY RESEARCH; FEMALE; HISTOPATHOLOGY; HUMAN; MALE; NUCLEAR MAGNETIC RESONANCE SCANNER; PREDICTIVE VALUE; PRIORITY JOURNAL; PROSPECTIVE STUDY; RECEIVER OPERATING CHARACTERISTIC; SENSITIVITY AND SPECIFICITY; TREATMENT RESPONSE; TUMOR DIFFERENTIATION; TUMOR REGRESSION; ADJUVANT THERAPY; ESOPHAGEAL NEOPLASMS; MIDDLE AGED; PATHOLOGY; PROCEDURES; TREATMENT OUTCOME;

AGED; CHEMORADIOTHERAPY; DIFFUSION MAGNETIC RESONANCE IMAGING; ESOPHAGEAL NEOPLASMS; FEMALE; HUMANS; MALE; MIDDLE AGED; NEOADJUVANT THERAPY; TREATMENT OUTCOME;

EID: 84931573212     PISSN: 01678140     EISSN: 18790887     Source Type: Journal    
DOI: 10.1016/j.radonc.2015.04.027     Document Type: Article

References (41)

1. K.M. Sjoquist, B.H. Burmeister, B.M. Smithers, and et al. Survival after neoadjuvant chemotherapy or chemoradiotherapy for resectable oesophageal carcinoma: an updated meta-analysis Lancet Oncol 12 2011 681 692
2. P. van Hagen, M.C. Hulshof, J.J. van Lanschot, and et al. Preoperative chemoradiotherapy for esophageal or junctional cancer N Engl J Med 366 2012 2074 2084
3. V. Oppedijk, A. van der Gaast, J.J. van Lanschot, and et al. Patterns of recurrence after surgery alone versus preoperative chemoradiotherapy and surgery in the CROSS trials J Clin Oncol 32 2014 385 391
4. A.C. Berger, J. Farma, W.J. Scott, and et al. Complete response to neoadjuvant chemoradiotherapy in esophageal carcinoma is associated with significantly improved survival J Clin Oncol 23 2005 4330 4337
5. J.M. Donahue, F.C. Nichols, and Z. Li Complete pathologic response after neoadjuvant chemoradiotherapy for esophageal cancer is associated with enhanced survival Ann Thorac Surg 87 2009 392 398 (discussion 398-9)
6. M. Stahl, M. Stuschke, N. Lehmann, and et al. Chemoradiation with and without surgery in patients with locally advanced squamous cell carcinoma of the esophagus J Clin Oncol 23 2005 2310 2317
7. L. Bedenne, P. Michel, O. Bouche, and et al. Chemoradiation followed by surgery compared with chemoradiation alone in squamous cancer of the esophagus: FFCD 9102 J Clin Oncol 25 2007 1160 1168
8. A. Habr-Gama, R.O. Perez, and W. Nadalin Operative versus nonoperative treatment for stage 0 distal rectal cancer following chemoradiation therapy: long-term results Ann Surg 240 2004 711 717 (discussion 717-8)
9. M. Maas, R.G. Beets-Tan, D.M. Lambregts, and et al. Wait-and-see policy for clinical complete responders after chemoradiation for rectal cancer J Clin Oncol 29 2011 4633 4640
10. R.M. Kwee Prediction of tumor response to neoadjuvant therapy in patients with esophageal cancer with use of 18F FDG PET: a systematic review Radiology 254 2010 707 717
11. Y.M. Chen, X.F. Pan, L.J. Tong, Y.P. Shi, and T. Chen Can (1)(8)F-fluorodeoxyglucose positron emission tomography predict responses to neoadjuvant therapy in oesophageal cancer patients? A meta-analysis Nucl Med Commun 32 2011 1005 1010
12. P.M. Schneider, R. Metzger, H. Schaefer, and et al. Response evaluation by endoscopy, rebiopsy, and endoscopic ultrasound does not accurately predict histopathologic regression after neoadjuvant chemoradiation for esophageal cancer Ann Surg 248 2008 902 908
13. M. Westerterp, H.L. van Westreenen, J.B. Reitsma, and et al. Esophageal cancer: CT, endoscopic US, and FDG PET for assessment of response to neoadjuvant therapy-systematic review Radiology 236 2005 841 851
14. D.M. Koh, and D.J. Collins Diffusion-weighted MRI in the body: applications and challenges in oncology AJR Am J Roentgenol 188 2007 1622 1635
15. M. Lambrecht, V. Vandecaveye, F. De Keyzer, and et al. Value of diffusion-weighted magnetic resonance imaging for prediction and early assessment of response to neoadjuvant radiochemotherapy in rectal cancer: preliminary results Int J Radiat Oncol Biol Phys 82 2012 863 870
16. A.R. Padhani, G. Liu, D.M. Koh, and et al. Diffusion-weighted magnetic resonance imaging as a cancer biomarker: consensus and recommendations Neoplasia 11 2009 102 125
17. H.C. Thoeny, and B.D. Ross Predicting and monitoring cancer treatment response with diffusion-weighted MRI J Magn Reson Imaging 32 2010 2 16
18. Y. Mardor, R. Pfeffer, R. Spiegelmann, and et al. Early detection of response to radiation therapy in patients with brain malignancies using conventional and high b-value diffusion-weighted magnetic resonance imaging J Clin Oncol 21 2003 1094 1100
19. V. Vandecaveye, P. Dirix, F. De Keyzer, and et al. Diffusion-weighted magnetic resonance imaging early after chemoradiotherapy to monitor treatment response in head-and-neck squamous cell carcinoma Int J Radiat Oncol Biol Phys 82 2012 1098 1107
20. M.D. Pickles, P. Gibbs, M. Lowry, and L.W. Turnbull Diffusion changes precede size reduction in neoadjuvant treatment of breast cancer Magn Reson Imaging 24 2006 843 847
21. C. Powell, M. Schmidt, M. Borri, and et al. Changes in functional imaging parameters following induction chemotherapy have important implications for individualised patient-based treatment regimens for advanced head and neck cancer Radiother Oncol 106 2013 112 117
22. I. Joye, C.M. Deroose, V. Vandecaveye, and K. Haustermans The role of diffusion-weighted MRI and (18)F-FDG PET/CT in the prediction of pathologic complete response after radiochemotherapy for rectal cancer: a systematic review Radiother Oncol 113 2014 158 165
23. G. Decker, P. Murtz, J. Gieseke, and et al. Intensity-modulated radiotherapy of the prostate: dynamic ADC monitoring by DWI at 3.0T Radiother Oncol 113 2014 115 120
24. K. Ott, W.A. Weber, F. Lordick, and et al. Metabolic imaging predicts response, survival, and recurrence in adenocarcinomas of the esophagogastric junction J Clin Oncol 24 2006 4692 4698
25. F.M. Lever, I.M. Lips, S.P. Crijns, and et al. Quantification of esophageal tumor motion on cine-magnetic resonance imaging Int J Radiat Oncol Biol Phys 88 2014 419 424
26. G.H. Bol, A.N. Kotte, U.A. van der Heide, and J.J. Lagendijk Simultaneous multi-modality ROI delineation in clinical practice Comput Methods Programs Biomed 96 2009 133 140
27. D.M. Lambregts, G.L. Beets, M. Maas, and et al. Tumour ADC measurements in rectal cancer: effect of ROI methods on ADC values and interobserver variability Eur Radiol 21 2011 2567 2574
28. M. Intven, O. Reerink, and M.E. Philippens Diffusion-weighted MRI in locally advanced rectal cancer: pathological response prediction after neo-adjuvant radiochemotherapy Strahlenther Onkol 189 2013 117 122
29. T.W. Rice, E.H. Blackstone, and V.W. Rusch 7th edition of the AJCC Cancer Staging Manual: esophagus and esophagogastric junction Ann Surg Oncol 17 2010 1721 1724
30. A.M. Mandard, F. Dalibard, J.C. Mandard, and et al. Pathologic assessment of tumor regression after preoperative chemoradiotherapy of esophageal carcinoma Clinicopathologic correlations Cancer 73 1994 2680 2686
31. T. Aoyagi, K. Shuto, S. Okazumi, H. Shimada, T. Kazama, and H. Matsubara Apparent diffusion coefficient values measured by diffusion-weighted imaging predict chemoradiotherapeutic effect for advanced esophageal cancer Dig Surg 28 2011 252 257
32. F. De Cobelli, F. Giganti, E. Orsenigo, and et al. Apparent diffusion coefficient modifications in assessing gastro-oesophageal cancer response to neoadjuvant treatment: comparison with tumour regression grade at histology Eur Radiol 23 2013 2165 2174
33. R.M. Kwee, A.K. Dik, M.N. Sosef, and et al. Interobserver reproducibility of diffusion-weighted MRI in monitoring tumor response to neoadjuvant therapy in esophageal cancer PLoS One 9 2014 e92211
34. T. Aoyagi, K. Shuto, S. Okazumi, and et al. Evaluation of the clinical staging of esophageal cancer by using diffusion-weighted imaging Exp Ther Med 1 2010 847 851
35. V. Vandecaveye, P. Dirix, F. De Keyzer, and et al. Predictive value of diffusion-weighted magnetic resonance imaging during chemoradiotherapy for head and neck squamous cell carcinoma Eur Radiol 20 2010 1703 1714
36. S. Kim, L. Loevner, H. Quon, and et al. Diffusion-weighted magnetic resonance imaging for predicting and detecting early response to chemoradiation therapy of squamous cell carcinomas of the head and neck Clin Cancer Res 15 2009 986 994
37. R.J. Theilmann, R. Borders, T.P. Trouard, and et al. Changes in water mobility measured by diffusion MRI predict response of metastatic breast cancer to chemotherapy Neoplasia 6 2004 831 837
38. Y. Cui, X.P. Zhang, Y.S. Sun, L. Tang, and L. Shen Apparent diffusion coefficient: potential imaging biomarker for prediction and early detection of response to chemotherapy in hepatic metastases Radiology 248 2008 894 900
39. Y.S. Sun, X.P. Zhang, L. Tang, and et al. Locally advanced rectal carcinoma treated with preoperative chemotherapy and radiation therapy: preliminary analysis of diffusion-weighted MR imaging for early detection of tumor histopathologic downstaging Radiology 254 2010 170 178
40. D. Le Bihan, C. Poupon, A. Amadon, and F. Lethimonnier Artifacts and pitfalls in diffusion MRI J Magn Reson Imaging 24 2006 478 488
41. S.H. Park, W.K. Moon, N. Cho, and et al. Comparison of diffusion-weighted MR imaging and FDG PET/CT to predict pathological complete response to neoadjuvant chemotherapy in patients with breast cancer Eur Radiol 22 2012 18 25